FDA Drug Application (020773) for SONORX by BRACCO

Back to FDA Applications sponsored by BRACCO

Application Number020773
Product Number001
FormSUSPENSION;ORAL
Dosage7.5MG/ML
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameSONORX
Active IngredientSIMETHICONE-CELLULOSE



Back to FDA Applications sponsored by BRACCO